Novel specializes in the development and manufacturing of orally-disintegrating, liquid, modified-release, powder, and rectal dosage forms. The Company currently employs a team of 85 highly qualified and motivated professionals who are dedicated to researching and developing pharmaceuticals of the highest quality. The staff pridesitself on its ability to develop cost-efficient, reproducible processes on an accelerated timeline that readiy comply with current Good manufacturing Practices.